The radiopharmaceutical market is on an upward trajectory, highlighted by a projected market size of $18.52 billion by 2035, showcasing a compound annual growth rate (CAGR) of 9.12%. This remarkable expansion is fueled by advancements in nuclear medicine and rising demand for personalized therapies, which allow for tailored treatment approaches. As the healthcare landscape evolves, the...